Maze Therapeutics (MAZE) EPS (Basic) (2024 - 2026)

Maze Therapeutics (MAZE) reported EPS (Basic) of -$0.36 for Q1 2026, up 68.25% on a YoY basis from -$0.22 in Q1 2025, and down 122.16% sequentially from -$0.16 in Q4 2025.

Maze Therapeutics (MAZE) EPS (Basic) (2024 - 2026) Analysis & Trends

Maze Therapeutics (MAZE) has 3 years of EPS (Basic) data on file, last reported at -$0.36 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 68.25% year-over-year to -$0.36; the trailing twelve-month figure through Mar 2026 stood at -$1.68 (down 214.55% YoY), and the FY2025 full-year result was -$3.05, down 314.7% from the prior year.
  • EPS (Basic) slipped to -$0.36 in Q1 2026, from -$0.16 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $58.2 in Q2 2024 to a low of -$16.54 in Q4 2024.
  • A 3-year average of $1.83 and a median of -$0.77 in 2025 frame the typical range for EPS (Basic).
  • Peak annual rise in EPS (Basic) reached 99.01% in 2025, while the deepest fall reached 101.32% in 2025.
  • Tracing MAZE's EPS (Basic) over 3 years: stood at -$16.54 in 2024, then soared by 99.01% to -$0.16 in 2025, then plunged by 122.16% to -$0.36 in 2026.
  • Business Quant data shows MAZE's EPS (Basic) at -$0.36 in Q1 2026, -$0.16 in Q4 2025, and -$0.66 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Maze Therapeutics 1.49 Bn 1.49 Bn 18.21 Mn -0.36

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.36
Dec 31, 2025 -0.16
Sep 30, 2025 -0.66
Jun 30, 2025 -0.77
Mar 31, 2025 -1.15
Dec 31, 2024 -16.54
Sep 30, 2024 -10.24
Jun 30, 2024 58.20
Mar 31, 2024 -11.87